RxDoctor Payments Data

Jeffrey Crist

Knoxville, TNNPI 1255318762

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.6% of the total across 236 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 27.2% of the total.

$3,311in general payments, 2019–2025

Across 236 payments — averaging $14.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$900
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$703
  • Johnson & Johnson$306
  • Takeda Pharmaceuticals U.S.A., Inc.$273
  • Braintree Laboratories, Inc.$244
  • Ferring Pharmaceuticals Inc.$223
  • plus $663 from 12 others

What the payments were for

  • Food & beverage$3,13295%
  • Gifts$1795%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Where these figures come from

Is this you, or does something look wrong? →